Zymergen is a company within the Biotechnology category. Zymergen was a science and material innovation company that pioneered the field of 'bio-facturing.' Utilizing machine learning, automation, and synthetic biology, the company developed novel materials by engineering microbes to produce high-value molecules for applications in electronics, agriculture, and healthcare. Following financial and technical setbacks, it was acquired by Ginkgo Bioworks in late 2022.
Zymergen was founded in 2013 and is headquartered in Emeryville, CA.
Zymergen is part of Ginkgo Bioworks.
Zymergen is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Zymergen is Moderate. Significant factual deltas detected.
AI models classify Zymergen as a Phantom. Invisible to AI.
Zymergen appeared in 2 of 6 sampled buyer-intent queries (33%). Zymergen appears in historical and educational queries regarding synthetic biology, but is no longer a 'solution' for active buyer queries.
AI provides a clear narrative of a "fallen unicorn." It accurately tracks the journey from a highly-funded synthetic biology leader to a cautionary tale of commercial over-promise, culminating in its 2022 acquisition. Key gap: The most likely gap is the current operational status; models may occasionally refer to Zymergen in the present tense as an independent entity if relying on data from early 2022.
Of 5 key facts verified about Zymergen, 5 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Mischaracterization of current product availability, as most independent Zymergen product lines were integrated or pivoted following the acquisition.
Buyers turn to Zymergen for Traditional Petrochemical Manufacturing: Traditional chemical manufacturing using petroleum-based processes and manual lab experimentation., Specialized R&D Consultancies: Consulting firms specialized in bio-engineering and materials science., among 2 documented problem areas.
Buyers evaluating Zymergen typically ask AI models about "best bio-manufacturing partners 2024", "What happened to Hyaline polyimide film?", "Who did Ginkgo Bioworks acquire?", and 1 similar queries.
Buyers commonly compare Zymergen with alternative to petroleum based plastics for electronics, Zymergen pricing for materials development, among 2 documented comparison brands.
Zymergen's main competitors are Amyris, Inc., Genomatica (Geno), Ginkgo Bioworks. According to AI models, these are the brands most frequently named alongside Zymergen in buyer-intent queries.
Zymergen's core products are Bio-factured materials, microbe engineering platform, Hyaline polyimide film (historical).
Zymergen uses Enterprise/Custom R&D contracts (historical).
Zymergen serves Electronics, Agriculture, Personal Care, Healthcare.
Zymergen Integrating machine learning and robotics with biology to discover and manufacture chemicals more efficiently than traditional methods.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Phantom
https://optimly.ai/brand/zymergen-acquired-by-ginkgo
Last analyzed: April 10, 2026
Founded: 2013
Headquarters: Emeryville, California, USA